| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.66 | 0.01 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |